Novartis makes it official: Alcon is moving its HQ from Texas to Geneva ahead of a spinoff
Alcon is losing its Texas accent.
Novartis $NVS CEO Vas Narasimhan put out the word this morning that the Basel-based pharma giant is moving Alcon’s headquarters to Geneva — ahead of a planned spinoff and public listing next year.
After the move the big Novartis eye care division will have up to 700 people based in the tax-friendly Swiss canton, which already hosts a large regional group. And Alcon will make its current headquarters in Fort Worth, Texas a division of the company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.